168 related articles for article (PubMed ID: 34230020)
1. 'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.
Standing H; Thomson RG; Flynn D; Hughes J; Joyce K; Lobban T; Lord S; Matlock DD; McComb JM; Paes P; Wilkinson C; Exley C
BMJ Open; 2021 Jul; 11(7):e048024. PubMed ID: 34230020
[TBL] [Abstract][Full Text] [Related]
2. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
5. Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.
MacIver J; Tibbles A; Billia F; Ross H
SAGE Open Med; 2016; 4():2050312116642693. PubMed ID: 27110361
[TBL] [Abstract][Full Text] [Related]
6. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
[TBL] [Abstract][Full Text] [Related]
8. Improving Communication in Heart Failure Patient Care.
Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
Freemantle M; Murtagh F
BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
[TBL] [Abstract][Full Text] [Related]
10. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
[TBL] [Abstract][Full Text] [Related]
11. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
[TBL] [Abstract][Full Text] [Related]
12. Quality dying: An approach to ICD deactivation in the hospital setting.
Turner S; Torabi S; Stilos K
Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
[TBL] [Abstract][Full Text] [Related]
13. Communication regarding the deactivation of implantable cardioverter-defibrillators: A scoping review and narrative summary of current interventions.
Callaghan EM; Diamandis-Nikoletatos E; van Leeuwen PP; Higgins JB; Somerville CE; Brown LJ; Schumacher TL
Patient Educ Couns; 2022 Dec; 105(12):3431-3445. PubMed ID: 36055906
[TBL] [Abstract][Full Text] [Related]
14. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
Herman M; Horner K; Ly J; Vayl Y
J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
[TBL] [Abstract][Full Text] [Related]
15. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
[TBL] [Abstract][Full Text] [Related]
16. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with ICDs at the end of life (EOL): a qualitative study.
Kelley AS; Mehta SS; Reid MC
Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
19. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?
Thylén I; Moser DK; Chung ML; Miller J; Fluur C; Strömberg A
Int J Cardiol Heart Vessel; 2013 Dec; 1():22-31. PubMed ID: 29450154
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
